Nvidia-backed CoreWeave targets up to $32 billion valuation in test for AI IPOs
By Manya Saini and Niket Nishant (Reuters) -CoreWeave is targeting a valuation of up to $32 billion on a fully diluted basis in its U.S.
NBA-Reigning champion Celtics agree to record-breaking $6.1 billion sale
(Reuters) – The reigning NBA champion Boston Celtics have agreed to a $6.1 billion sale to a group headed by private equity firm Symphony Technology
Nvidia CEO says orders for 3.6 million Blackwell GPUs exclude Meta
(Reuters) -Nvidia CEO Jensen Huang said on Wednesday that orders for some 3.6 million of its flagship “Blackwell” chips from four top cloud service providers
Zelenskiy says he had substantive call with Trump discussing partial ceasefire, air defences
(Reuters) – Ukrainian and U.S. teams could meet in Saudi Arabia in the coming days to discuss technicalities of partial ceasefire, President Volodymyr Zelenskiy said
General Mills forecasts hit to annual sales, profit as snacking demand slows
By Neil J Kanatt (Reuters) -General Mills cut its annual sales and profit forecasts on Wednesday, as the Pillsbury owner takes a hit from choppy
Feds says will slow balance sheet runoff process
By Michael S. Derby WASHINGTON (Reuters) – The Federal Reserve said on Wednesday that it will reduce the pace of the drawdown of its still-massive
US appeals court rejects copyrights for AI-generated art lacking ‘human’ creator
By Blake Brittain A federal appeals court in Washington, D.C., on Tuesday affirmed that a work of art generated by artificial intelligence without human input
USDA to begin disbursing economic aid to farmers amid low prices
By Leah Douglas (Reuters) – The U.S. Department of Agriculture will on Wednesday begin accepting applications from farmers affected by low commodity prices for economic
Adobe rolls out AI agents for online marketing toolsÂ
By Stephen Nellis SAN FRANCISCO (Reuters) – Adobe on Tuesday said it is rolling out artificial intelligence “agents” that brands can use to help consumers
Factbox-Widely used drugs on US imports list from Europe
(Reuters) – Widely used prescription medicines could get caught up in the Trump administration’s tariff trade wars and EU retaliation. The following is a list